You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unfavorable intermediate risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)

Not yet recruiting
  • Prostate Cancer
  • Relugolix 120 MG [Orgovyx]
  • SBRT standard of care radiotherapy treatment
  • New Haven, Connecticut
    Yale Cancer Center
Oct 26, 2023

Prostate Cancer Trial in Rome (Decapeptyl)

Recruiting
  • Prostate Cancer
  • Rome, Lazio, Italy
  • +2 more
Sep 23, 2022

Prostate Cancer, Cancer of the Prostate Trial in Saint Louis (device, radiation, drug)

Recruiting
  • Prostate Cancer
  • Cancer of the Prostate
  • Ethos Varian treatment system
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 19, 2023

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Prostate Cancer Trial in United States (Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • Prostate Cancer
  • Stereotactic Body Radiation Therapy (SBRT)
  • Basking Ridge, New Jersey
  • +6 more
Feb 23, 2022

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Recruiting
  • Prostate Cancer
    • Monza, MB, Italy
      Radiation Oncology, ASST Monza (University of Milan Bicocca)
    Jul 21, 2022

    Prostate Cancer Trial in France (Association of darolutamide and EBRT, Association of ADT and EBRT)

    Not yet recruiting
    • Prostate Cancer
    • Association of darolutamide and EBRT
    • Association of ADT and EBRT
    • Avignon, France
    • +9 more
    Apr 21, 2022

    Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate

    Active, not recruiting
    • Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
    • +8 more
    • Computed Tomography
    • +3 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Feb 10, 2022

    Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)

    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiosurgical Boost
    • +2 more
    • Sacramento, California
      UC Davis Sacramento Cancer Center Dept of Radiation Oncology
    Sep 24, 2021

    Prostate Cancer Trial in Boston, Philadelphia (NBTXR3 activated by IMRT only, NBTXR3 activated by Brachytherapy & IMRT)

    Terminated
    • Prostate Cancer
    • NBTXR3 activated by IMRT only
    • NBTXR3 activated by Brachytherapy & IMRT
    • Boston, Massachusetts
    • +1 more
    May 5, 2021

    Prostate Cancer, Prostate Adenocarcinoma Trial in Charlottesville (External Beam Radiation, HDR Brachytherapy, Androgen

    Recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • External Beam Radiation
    • +2 more
    • Charlottesville, Virginia
      University of Virginia
    Oct 23, 2020

    Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

    Not yet recruiting
    • Rhabdomyosarcoma
    • Palo Alto, California
    • +2 more
    Aug 27, 2023

    Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)

    Recruiting
    • Pulmonary Embolism
    • ultrasound-assisted, catheter-directed thrombolysis
    • Milano, Italia, Italy
      ASST GOM Niguarda
    Nov 21, 2023

    Intermediate to High-risk Asymptomatic Sportsmen With Exercise

    Completed
    • Electrocardiography
    • Screening stress test on a bicycle ergometer (usual practise)
    • Saint-Étienne, France
      Centre Hospitalier de Saint-Etienne
    Sep 6, 2023

    Prostate Cancer Trial in San Francisco (Carbon C 11 Choline, Fluorine F 18 Choline, Positron Emission Tomography (PET) /

    Completed
    Has Results
    • Prostate Cancer
    • Carbon C 11 Choline
    • +2 more
    • San Francisco, California
      University of California San Francisco
    Oct 27, 2020

    Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -

    Not yet recruiting
    • Anal Squamous Cell Carcinoma
    • Radiotherapy - Low risk group
    • +3 more
    • (no location specified)
    Sep 18, 2023

    Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)

    Recruiting
    • Prostate Cancer
    • [18F]Florastamin Injection
    • Guangzhou, China
      Sun Yat-sen University Cancer Center
    Aug 21, 2023

    Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

    Not yet recruiting
    • Localized Prostate Carcinoma
    • +3 more
    • Degarelix
    • MRI-guided transurethral ultrasound ablation (TULSA)
    • Turku, Southwest Finland, Finland
      Turku University Hospital
    Jun 14, 2023

    Smoldering Multiple Myeloma Trial (Selinexor)

    Not yet recruiting
    • Smoldering Multiple Myeloma
    • (no location specified)
    Oct 27, 2022

    Pulmonary Embolism Subacute Massive Trial (Mechanical embolectomy: by hydromechanical defragmentation by pigtail, Suction

    Not yet recruiting
    • Pulmonary Embolism Subacute Massive
    • Mechanical embolectomy: by hydromechanical defragmentation by pigtail
    • Suction embolectomy by the Penumbra Indigo aspiration system
    • (no location specified)
    Nov 9, 2022

    Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

    Recruiting
    • Pre-fibrotic Myelofibrosis
    • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
    • Taipei, Taiwan, 100, Taiwan
      National Taiwan University Hospital
    Feb 7, 2023

    Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])

    Not yet recruiting
    • Prostate Cancer
    • Piflufolastat F 18 Intravenous Solution [PYLARIFY]
    • (no location specified)
    Oct 3, 2023

    Screening CEDM in Intermediate and High-Risk Patient Populations

    Completed
    • Breast Cancer
    • Contrast Enhanced Digital Mammography
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jan 18, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

    Completed
    • Squamous Cell Carcinoma of Head and Neck
    • sEphB4-HSA with chemotherapy
    • +2 more
    • Aurora, Colorado
      University of Colorado Hospital
    Dec 9, 2022